Suggestions
Ted Slafsky
Publisher and CEO of 340B Report and Founder and Principal of Wexford Solutions
Ted Slafsky is the Publisher and Chief Executive Officer of 340B Report, a subscription-based news service focused on covering developments in the federal 340B drug pricing program.13 He is a long-time healthcare thought leader and journalist with three decades of experience in 340B and journalism.1
Some key points about Ted Slafsky's background and career:
-
He is the Founder & Principal of Wexford Solutions LLC, a consulting firm.15
-
Slafsky began his career as an award-winning reporter and researcher at U.S. News & World Report.1
-
He served in senior leadership for 22 years at 340B Health, a Washington D.C.-based association of over 1400 hospitals and health systems in the 340B program. He started as executive director and was later elevated to President & CEO.1
-
During his tenure at 340B Health, he co-founded and led the 340B Coalition, an umbrella group of national organizations representing 340B providers.1
-
Slafsky is recognized as a national expert and thought leader on healthcare access and prescription drug pricing.2
-
He launched 340B Report in February 2020 as a new venture in addition to his role at Wexford Solutions.6
Ted Slafsky's LinkedIn profile can be found under the username ted-slafsky-12859793, where he shares insights and updates related to the 340B program and healthcare industry.24
Highlights
News Alert from 340B Report:
EMD Serono Extends 340B Contract Pharmacy Restrictions to All Covered Entities & Adds New Restrictions - https://lnkd.in/d-gt27Qb
To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg
#340B #pharmacy #drugpricing #hospitals #hospitalpharmacy
The latest from 340B Report:
Hospital Groups Urge HRSA to Take ‘Immediate Enforcement Action’ Against J&J’s Contested 340B Rebate Proposal - https://lnkd.in/eAxjhP-g
Analysis Finds Growing Private Equity, Corporate Investments in 340B; Firm Conducting Study Fails to Mention Its Own PE Funding - https://lnkd.in/eXKTXnNe
Preparing for a Neutral 340B Claims Clearinghouse - https://lnkd.in/eF-qPUV2
State Contract Pharmacy Lawsuit Weekly Roundup: Judge Calls Astra Subpoenas ‘Overly Broad,’ Mo. Officials Push to Dismiss Lawsuit - https://lnkd.in/euYbpbTx
Two More Drugmakers Partially Exempt Missouri Providers from 340B Contract Pharmacy Restrictions - https://lnkd.in/eun8DYMA
340B INDUSTRY LEADER SPOTLIGHT Christina Breckenridge, Senior Director of Client Success, RxStrategies - https://lnkd.in/eQtAF5p5
To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg
#340B #pharmacy #drugpricing #hospitals #hospitalpharmacy
